6ème Conférence sur le traitement des addictions de SEEA Net

We are proud to welcome you all in a beautiful city of Tirana together with many colleagues throughout SEEA region and numerous international representatives, representing as well the partnership that SEEA net has developed with AKSION PLUS ASSOCIATION, EUROPAD, UNFPA, UNICEF, UNODC, WHO and other international organizations and members of the World Federation for the Treatment of Opioid Dependence.

SEEA net 2012 is a meeting that anyone concerned with the people who benefit from our services will want to attend.

The main conference topics are treatment of young drug users, patients with comorbidity and cooperation with existent drug prevention and treatment services, medical, social and other services and NGOs in the region, treatment of Hepatitis C, different praxis through the region and treatment in custodial settings.

The organisers are excited about hopefully an excellent conference programme developed by our conference planning committees and coming together at nonformal meetings such as the welcome reception, awards party and other social events.

The conference site, the Tirana International Hotel is in the center of Tirana, so be sure to make accommodation reservations as soon as possible.

We hope that many of you take time to visit Tirana, Albania to celebrate SEEA net Conference and Symposium and to be a part of the premier addiction treatment conference in the region.

Important Dates

• Apr 30, 2012 - Abstract Submission

• Apr 30, 2012 - Early Registration and Payment

• May 15, 2012 - Notification of Acceptance

• Jun 15, 2012 - Registration Deadline

Contact

Information for scientific programme:

• Andrej Kastelic (andrej.kastelic@guest.arnes.si, tel. + 386 1 5874 981 or mobile: +386 41 683139, fax: +386 1 5874990)

• Genci Muçollari (GENCAXIONP@albmail.com, tel./fax +335 4 2259139, or mobile+ 335 69 2066359)

All other information: seea.net@gmail.com

For more information including a preliminary programme, please click here.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.